Clinical Trial Update: Antenatal Development Evaluated Prospectively [NA]

View source ↗

Summary

A clinical trial evaluating antenatal fetal development (fetal growth restriction and macrosomia) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Macrosomia

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Retardation, Fetal Growth, Macrosomia, Fetal | NA | Status: WITHDRAWN